Neuroblastoma Research

New strategy for alerting central nervous system toxicity: Integration of blood-brain barrier toxicity and permeability in neurotoxicity assessment.

Related Articles New strategy for alerting central nervous system toxicity: Integration of blood-brain barrier toxicity and permeability in neurotoxicity assessment. Toxicol In Vitro. 2009 Apr;23(3):447-53 Authors: Hallier-Vanuxeem D, Prieto P, Culot...

Posted Jun 12 2009, 09:08 AM by pubmed: neuroblastoma

Filed under: Toxicol In Vitro

[Results of infantile neuroblastoma treatment in the Republic of Belarus]

[Results of infantile neuroblastoma treatment in the Republic of Belarus] Vopr Onkol. 2009;55(2):215-20 Authors: Our investigation was concerned with effectiveness of infantile neuroblastoma treatment in Belarus and dependence of prognosis on extent of...

Posted Jun 12 2009, 09:08 AM by pubmed: neuroblastoma

Filed under: Vopr Onkol

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study. Lancet Oncol. 2009 Jun 8; Authors: Vermeulen J, De Preter K, Naranjo A, Vercruysse L, Van Roy N, Hellemans J, Swerts K,...

Posted Jun 12 2009, 09:08 AM by pubmed: neuroblastoma

Filed under: Lancet Oncol

The Neuroprotective Effects of Ginsenosides on Calcineurin Activity and Tau Phosphorylation in SY5Y Cells.

The Neuroprotective Effects of Ginsenosides on Calcineurin Activity and Tau Phosphorylation in SY5Y Cells. Cell Mol Neurobiol. 2009 Jun 11; Authors: Tu LH, Ma J, Liu HP, Wang RR, Luo J Calcineurin (CN) is a Ca(2+)/calmodulin-dependent protein phosphatase...

Posted Jun 12 2009, 09:08 AM by pubmed: neuroblastoma

Filed under: Cell Mol Neurobiol

Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway.

Related Articles Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway. Mol Cancer Ther. 2009 Jun 9; Authors: Thress K, Macintyre T, Wang H, Whitston D, Liu ZY, Hoffmann...

Posted Jun 11 2009, 09:22 AM by pubmed: neuroblastoma

Filed under: Mol Cancer Ther

Small-molecule BH3 mimetics to antagonize Bcl-2-homolog survival functions in cancer.

Related Articles Small-molecule BH3 mimetics to antagonize Bcl-2-homolog survival functions in cancer. Curr Opin Investig Drugs. 2009 Jun;10(6):559-71 Authors: Goldsmith KC, Hogarty MD Cancer arises through genetic alterations that improve cellular fitness...

Posted Jun 11 2009, 09:22 AM by pubmed: neuroblastoma

Filed under: Curr Opin Investig Drugs

N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons.

Related Articles N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons. J Neurochem. 2009 May;109(3):807-18 Authors: Kazantseva A, Sepp M, Kazantseva J, Sadam H, Pruunsild P, Timmusk T, Neuman T, Palm K The...